rifaximinbeta-blockersdiureticscirrhosistertiary hepatology centre
…s) and liver-related pharmacotherapy (beta-blockers, diuretics, rifaximin) were collected. Models using baseline variables to predict 6-m…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 2,341–2,400 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
polatuzumab2praziquantel2progestin2propofol-based2protease inhibitors2psycholeptics2psychotropic medications2psychotropics2pulse methylprednisolone2raltegravir2recombinant tissue plasminogen activator2renin2riluzole2salmeterol2scopolamine2secnidazole2slow-release oral morphine2sodium chloride2sodium glucose cotransporter 2 inhibitors2sodium-glucose cotransporter-2 (SGLT-2) inhibitors2sofosbuvir/velpatasvir2somatostatin analogues2sufentanil-based2sulfadoxine-pyrimethamine2sulphonamides2systemic opioids2systemic steroids2tegileridine-based2teriparatide2tetrahydrocannabinol2therapeutic antibodies2thimerosal2thiomersal2thiopentone2third-generation cephalosporins2ticagrelor-treated2trimethylamine N-oxide2tumor necrosis factor-alpha2unfractionated heparin2ursodeoxycholic acid (UDCA) who have an inadequate response to UDCA2vandetanib2vascular endothelial growth factor (VEGF) inhibitors2vecuronium2vigabatrin2vinorelbine2vorinostat2vortioxetine2vosoritide2vutrisiran2zinc2zopiclone2αPD-L12eGDR1OGTT 1-h PG1IL-15SA1RAMP11camre1CAPOX1Cryoprecipitate1NP-1011
Articles mentioning drugs
10,506 articles · page 400 of 876SeHCATFunctional Bowel Diseasemicroscopic colitiscoeliac diseaseirritable bowel syndromeidiopathic BADCrohn’s disease
… groups 65 (29.1%) severe (<5% retention), 63 (28.2%) moderate (SeHCAT 5-10%), 47 (SeHCAT 10-15%) mild, 48 borderline (SeHCAT 15-20%).…
programmed cell death protein 1programmed death-ligand 1cytotoxic T-lymphocyte-associated protein 4cancerUS Veteran Health Administration
…inistration who received first-line or second-line ICI therapy (programmed cell death protein 1, programmed death-ligand 1, cytotoxic T-lymphocyte-associated p…
FIB-4NHS EnglandLiver diseaseMASLDARLDcACLDT2DMviral hepatitishepatocellular carcinoma
… results for patients who followed the pathway as per protocol. FIB-4 testing demonstrated reduced sensitivity in individuals with T2…
disitamab vedotintrastuzumab deruxtecanT-DXdgastric canceranti-HER2 therapy
…ody-drug conjugates, such as trastuzumab deruxtecan (T-DXd) and disitamab vedotin (RC48), has been pivotal in rendering ‘HER-2-low’ gastric cance…
bisphosphonatesrisedronatecirrhosisNOGGFRAX score
…ad high-risk endoscopic findings and were not suitable for oral bisphosphonates therapy. Four of these patients were treated with a single dose…
CeftriaxoneThird generation cephalosporinTGCdecompensated liver diseaseHepatitis CAFIThe Indus Hospital and Health Network
…cted on consecutive subjects with AFI who received of injection Ceftriaxone from January 2021 till September 2025 at The Indus Hospital and…
midazolamfentanylPropofolGORDgastro-oesophageal reflux disease (GORD)IRAS 304275
…, independent of reflux status.There was no correlation between midazolam or fentanyl dose and DI (all p>0.25). FLIP motility patterns we…
NSAIDfcSEMSNorth Bristol NHS TrustRoyal United Hospitals BathPEPERCP
… Due to inconsistent data, we could not adjust for prophylactic NSAID use or pancreatic stent placement, although almost all patients…
5ASAantiTNFCrohn’s diseaseCROCOBDISS monotherapy
…rianal involvement.Within six months of diagnosis, 18% received 5ASA, 30% systemic corticosteroids, 36% immunosuppressants, and 61% …
Etrasimodulcerative colitisUC
…Introduction Etrasimod is a novel oral selective S1PR modulator recommended for induct…
Tofacitinib15-ASA13Steroids2Crohn’s disease9ulcerative colitisCrohn’s diseaseVillous changesIndeterminate colitis3Villous changes30indeterminate colitis+1 more
…ry sclerosing cholangitis4 (8%)Baseline therapyBiologics26 (53%)Tofacitinib1 (2%)5-ASA13 (27%)Steroids2 (4%)No therapy7 (14%)Mayo Score at i…